Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Validea Market Legends ETF VALX Feb 24, 2017 0.27 0.00   
 Valley Financial Corp VYFC Feb 24, 2017 21.36 0.00   
 Valley National Bancorp VLYWW Feb 24, 2017 0.03 0.00   
 Value Line VALU Feb 24, 2017 18.28 +1.60   
 Valueclick Inc VCLK Feb 24, 2017 21.00 0.00   
 Valuevision Media VVTV Feb 24, 2017 6.08 0.00   
 Vanda Pharmaceuticals Inc VNDA Feb 24, 2017 13.80 +1.47   
 VanEck Vectors Biotech ETF BBH Feb 24, 2017 118.50 +0.28   
 VanEck Vectors Generic Drugs ETF GNRX Feb 24, 2017 22.53 -1.70   
 VanEck Vectors Pharmaceutical ETF PPH Feb 24, 2017 56.00 +0.11   
 Vanguard Emerging Markets Gover VWOB Feb 24, 2017 79.62 +0.32   
 Vanguard International Dividend Appreciation ETF VIGI Feb 24, 2017 56.02 -0.55   
 Vanguard International High Dividend Yield ETF VYMI Feb 24, 2017 59.43 -0.97   
 Vanguard Natural Resources LLC VNRCP Feb 24, 2017 2.00 0.00   
 Vanguard Natural Resources LLC VNRBP Feb 24, 2017 2.00 0.00   
 Vanguard Natural Resources Llc VNR Feb 24, 2017 0.20 0.00   
 Vanguard Natural Resources Llc Pfd. Series A VNRAP Feb 24, 2017 2.26 0.00   
 Vanguard Short-Term Inflation-P VTIP Feb 24, 2017 49.51 +0.18   
 Vanguard Total International Bo BNDX Feb 24, 2017 54.23 +0.30   
 Varonis Systems, Inc. VRNS Feb 24, 2017 27.70 0.00   
 Vasco Data Security International VDSI Feb 24, 2017 13.55 -0.37   
 Vascular Biogenics Ltd. VBLT Feb 24, 2017 5.60 -0.89   
 Vascular Solutions VASC Feb 24, 2017 56.00 0.00   
 VBI Vaccines, Inc. VBIV Feb 24, 2017 4.81 +1.91   
 Vca Antech WOOF Feb 24, 2017 90.98 +0.08   
 Vcg Holding Corp. VCGH Feb 24, 2017 2.24 0.00   
 Veeco Instruments Inc VECO Feb 24, 2017 28.25 -0.53   
 Velocityshares Emerging Asia Dr ASDR Feb 24, 2017 68.90 0.00   
 Velocityshares Emerging Markets EMDR Feb 24, 2017 49.28 0.00   
 Velocityshares Equal Risk Weigh ERW Feb 24, 2017 49.00 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK